The device earned FDA clearance and breakthrough designation earlier in 2024, and it features a pelvis-specific design to improve fixation and reduce the risk of screw backout. It is designed to address anatomic and biomechanical challenges of pelvic fractures, especially in patients with poor bone quality.
Edward Westrick, MD, of Pittsburgh-based Allegheny General Hospital; Reza Firoozabadi, MD, of Seattle-based Harborview Medical Center; J.D. Black, MD, of Richland, Wash.-based Kadlec Regional Medical Center, and Brian Cunningham, MD, of St. Louis Park, Minn.-based Methodist Hospital – HealthPartners were among the first surgeons to use the device.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
